At a glance
- Originator Cephalon France
- Class Antidepressants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 05 Jun 2001 Discontinued-Preclinical for Depression in France (Unknown route)
- 16 Aug 1996 Preclinical development for Depression in France (Unknown route)